UN SDG #3 Good Health and Well-being UN SDG #3
UN SDG #2 Zero Hunger UN SDG #2

challenge

0 shares

Treating dementia with a Unique Digital Social-Health Service Platform

Alzheimer’s disease is complex, and it is unlikely that any one drug or other intervention can successfully treat it. Researchers hope to develop therapies targeting specific genetic, molecular, and cellular mechanisms so that the actual underlying cause of the disease can be stopped or prevented.

challenge

0 shares

Treating dementia with a Unique Digital Social-Health Service Platform

Alzheimer’s disease is complex, and it is unlikely that any one drug or other intervention can successfully treat it. Researchers hope to develop therapies targeting specific genetic, molecular, and cellular mechanisms so that the actual underlying cause of the disease can be stopped or prevented.
5M
people impacted
$1.7T
potential funding
the problem
Nature and Context

Alzheimer’s disease is complex, and it is unlikely that any one drug or other intervention can successfully treat it. Current approaches focus on helping people maintain mental function, manage behavioral symptoms, and slow down certain problems, such as memory loss. Researchers hope to develop therapies targeting specific genetic, molecular, and cellular mechanisms so that the actual underlying cause of the disease can be stopped or prevented. Several medications are approved by the U.S. Food and Drug Administration (FDA) to treat symptoms of Alzheimer’s. These drugs work by regulating neurotransmitters, the chemicals that transmit messages between neurons. They may help reduce symptoms and help with certain behavioral problems. However, these drugs don’t change the underlying disease process. They are effective for some but not all people, and may help only for a limited time.

Symptoms and Causes
the impact
Negative Effects
Economic Impact
Success Metrics
who benefits from solving this problem
Organization Types
Stakeholders
financial insights
Current Funding
Potential Solution Funding
ideas
Ideas Description

Forty-seven million people suffer from Alzheimer’s worldwide and these figures are expected to triple by 2050. Today’s challenge is not only to cure Alzheimer’s, but to find out how to live with it, how to delay cognitive effects and how to improve the quality of life of both patients and their relatives. AlzhUp is an aggregator of scientifically validated non-pharmacological therapies, the first one being the ICAP Program, validated by the Spanish Ministry of Health. These therapies are completely customized to each patient, thanks to the personal bank of memories that catalogues memories using a scientific mnemonic algorithm that simulates real behavior of the human brain.

Ideas Value Proposition
Ideas Sustainability
attributions
Contributors to this Page